🔗 Share this article

An underground market for unapproved weight-loss medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning effects. Followers are encouraged to contact these accounts privately for supplier links, while also receiving discount codes.

Thriving Trade on Social Networks

Separately, a flourishing trade exists on messaging services, where communities with thousands of members share comparison images, injection guides and assertions of next-day UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for transactions.

Learning About Retatrutide

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials indicate it could help individuals lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Healthcare Professionals Voice Worries

However, physicians and pharmacists have cautions that the distribution of what is still an unlicensed medication in the UK is worrisome and could result in individuals injecting substances of uncertain source.

Several professionals stated the popularity for retatrutide could be linked to the increasing price of approved weight loss products such as Mounjaro.

Legal Position and Enforcement

Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or distributed for personal consumption under the British medical regulations.

Several content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled substance, but advertising and supply can still violate medicines, marketing, and consumer regulations, potentially leading to fines, legal action or prison.

Platform Response and Content Removal

According to the social media company, the platform has removed problematic material and banned associated keywords and query recommendations. The company stated it was dedicated to maintaining the platform secure and allocating resources in enhancing compliance measures.

Digital Trading Activities

Investigations also found groups with up to nine thousand members selling the experimental drug using the platform's integrated discovery tool, which operates like a public directory. Entering “retatrutide” instantly brings up channels with thousands of members, filled with photos of weight loss, positive testimonials and step-by-step guides for preparing or injecting at home.

Within moments of entering one community, a seller shared contact information, where the majority of purchases take place. The vendor provided an guidebook and promised shipping within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. None inquired about weight, health issues or previous experience.

Product Information and Costs

Within these groups, messages display black plastic parcels with Royal Mail stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with purified liquid, or ready-to-use pens typically sold at £160 for 20 milligrams. When questioned how long a injector should last, vendors give conflicting responses ranging from a several days to “depends on your body”.

Platform Moderation and Security Actions

A representative for the messaging service said it actively monitored harmful material on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“People are injecting materials they cannot confirm. Even if the science behind this drug is sound, these online products may not include what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, individuals are turning to social media. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was clean,” she said.

Her staff has previously encountered individuals harmed by self-injection from unverified sources. “We understand the frustration, but buying from Telegram or communication platforms is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can sell [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company experimental product not yet approved … may subject patients to potentially serious health risks”.